ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes

ClinicalTrials.gov ID: NCT06993792

Public ClinicalTrials.gov record NCT06993792. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 5:04 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Master Protocol to Investigate the Efficacy and Safety of Orforglipron Tablet Once Daily Compared With Placebo in Participants With Obesity or Overweight With and Without Type 2 Diabetes

Study identification

NCT ID
NCT06993792
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
1,200 participants

Conditions and interventions

Interventions

  • Orforglipron Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 14, 2025
Primary completion
Jul 31, 2027
Completion
Jul 31, 2027
Last update posted
Apr 23, 2026

2025 – 2027

United States locations

U.S. sites
35
U.S. states
14
U.S. cities
34
Facility City State ZIP Site status
Clinical Research Institute of Arizona (CRI) - Sun City West Sun City West Arizona 85375
Novak Clinical Research - Tucson - North La Cholla Boulevard Tucson Arizona 85741
Norcal Endocrinology & Internal Medicine San Ramon California 94583
Southern California Clinical Research Santa Ana California 92701
Care Access - Thousand Oaks Thousand Oaks California 91360
Accel Research Sites - DeLand Clinical Research Unit DeLand Florida 32720
Innovation Medical Research Center - Fort Lauderdale Fort Lauderdale Florida 33316
Indago Research & Health Center, Inc Hialeah Florida 33012
Encore Medical Research Hollywood Florida 33024
West Orange Endocrinology P.A. Ocoee Florida 34761
Care Access - Tampa Tampa Florida 33625
Conquest Research Winter Park Florida 32789
Accel Research Sites - NeuroStudies Clinical Research Unit Decatur Georgia 30030
Care Access - Decatur Decatur Georgia 30030
Javara - Privia Medical Group Georgia - Savannah Savannah Georgia 31406
North Georgia Clinical Research Woodstock Georgia 30189
Solaris Clinical Research Meridian Idaho 83646
Care Access - New Iberia New Iberia Louisiana 70560
Endocrine and Metabolic Consultants Rockville Maryland 20852
Javara - Privia Medical Group - Silver Spring Silver Spring Maryland 20901
Great Lakes Research Group, Inc. Bay City Michigan 48706
Boeson Research MSO Missoula Montana 59804
Javara - Nevada Health Centers - Carson City Carson City Nevada 89706
The Machuca Foundation Las Vegas Nevada 89101
University of North Carolina Medical Center Chapel Hill North Carolina 27514
Javara - Tryon Medical Partners Charlotte North Carolina 28210
Care Access - Fayetteville Fayetteville North Carolina 28314
The Corvallis Clinic, P.C. Corvallis Oregon 97330
Clinical Research of Philadelphia Philadelphia Pennsylvania 19114
Frontier Clinical Research, LLC Smithfield Pennsylvania 15478
Velocity Clinical Research, Dallas Dallas Texas 75230
Biopharma Informatic, LLC Houston Texas 77043
Activian Clinical Research Kingwood Texas 77339
Texas Valley Clinical Research (TVCR) - Mission Mission Texas 78572
Consano Clinical Research, LLC Shavano Park Texas 78231

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 45 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06993792, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 23, 2026 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06993792 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →